Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol for recurrent ventricular arrhythmia (ONO-1101-30)
jRCT2080222904Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of landiolol in ventricular tachycardia (VT), ventricular fibrillation (VF) and ventricular arrhythmia (VA), sponsored by Ono Pharmaceutical. Started Jul 2015; status: completed.
02
Drugs
landiolol
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on jRCT2080222904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222904.